GPS Wealth Strategies Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$129K Sell
1,516
-5,488
-78% -$450K 0.11% 125
2025
Q3
$545K Sell
7,004
-808
-10% -$63.1K 0.06% 178
2025
Q2
$611K Sell
7,812
-1,686
-18% -$126K 0.07% 158
2025
Q1
$688K Sell
9,498
-1,318
-12% -$94.3K 0.09% 138
2024
Q4
$801K Sell
10,816
-2,230
-17% -$156K 0.1% 122
2024
Q3
$861K Sell
13,046
-4,368
-25% -$317K 0.11% 126
2024
Q2
$1.61M Sell
17,414
-556
-3% -$49.2K 0.24% 75
2024
Q1
$1.72M Sell
17,970
-102
-0.6% -$8.57K 0.28% 74
2023
Q4
$1.38M Buy
18,072
+336
+2% +$23.4K 0.25% 77
2023
Q3
$1.23M Buy
17,736
+118
+0.7% +$9.48K 0.24% 81
2023
Q2
$1.66M Buy
17,618
+70
+0.4% +$6.08K 0.31% 62
2023
Q1
$1.45M Buy
17,548
+1,196
+7% +$94K 0.3% 63
2022
Q4
$1.22M Buy
16,352
+67
+0.4% +$5.16K 0.37% 60
2022
Q3
$1.35M Buy
16,285
+180
+1% +$17.3K 0.34% 55
2022
Q2
$1.53M Buy
16,105
+223
+1% +$23.1K 0.39% 51
2022
Q1
$1.87M Buy
15,882
+446
+3% +$50K 0.42% 42
2021
Q4
$2M Sell
15,436
-324
-2% -$37.8K 0.44% 38
2021
Q3
$1.78M Buy
15,760
+629
+4% +$71.8K 0.44% 40
2021
Q2
$1.57M Buy
15,131
+408
+3% +$38.5K 0.4% 45
2021
Q1
$1.23M Buy
14,723
+1,780
+14% +$150K 0.36% 45
2020
Q4
$1.18M Buy
12,943
+67
+0.5% +$5.56K 0.41% 45
2020
Q3
$1.03M Buy
+12,876
New +$1M 0.41% 44

Other funds holding EW

GPS Wealth Strategies Group's EW Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Edwards Lifesciences (EW) stake by 78% in Q4 2025, selling an estimated $450K and leaving 1,516 shares worth $129K. The position accounts for 0.11% of the portfolio, ranked #125.

GPS Wealth Strategies Group first reported a position in EW in Q3 2020 and has held it in 22 quarters since. The position peaked at $2M in Q4 2021. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • GPS Wealth Strategies Group held 1,516 shares of Edwards Lifesciences worth $129K as of Q4 2025.
  • GPS Wealth Strategies Group sold 5,488 Edwards Lifesciences shares in Q4 2025, an estimated $450K.
  • Edwards Lifesciences made up 0.11% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #125 holding.
  • GPS Wealth Strategies Group first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 22 quarters since.
  • GPS Wealth Strategies Group's Edwards Lifesciences position peaked at $2M in Q4 2021.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.